April 4, 2024
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Investors
Odyssey Overview
At Odyssey, we are advancing a diverse pipeline of transformative immunology and oncology medicines. Our team of world-class leaders and proven drug hunters is committed to creating extraordinary leaps in patient outcomes. Our breakthrough drug discovery and development model merges cutting-edge biology, chemistry, and data science, which allows us to solve some of the world’s most complex therapeutic challenges.
Investor Contact
name
email
phone
Media Contact
Michael Sullivan
[email protected]
(503) 799-7520
